The NT scan — or Nuchal Translucency scan — is the most important screening test available in the first trimester of pregnancy. Performed between 11 and 13 weeks and 6 days, it gives expectant parents an early, reliable assessment of their baby's chromosomal health, with particular relevance to Down syndrome, Edwards syndrome, and Patau syndrome. For parents in Delhi seeking a specialist-level scan rather than a routine diagnostic centre appointment, the Fetal & Genetic Clinic in Chittaranjan Park offers NT scans performed and interpreted personally by Dr. Ashutosh Gupta — a fetal medicine specialist with a DM in Medical Genetics from SGPGIMS, Lucknow, and more than 3,000 invasive fetal procedures to his name.
This page explains everything you need to know about the NT scan: what it measures, what the results mean, what happens when a result is elevated, and how the NT scan fits into the broader first-trimester screening programme.
What Is the NT Scan — And Why Is It Done at 12 Weeks?
The NT scan is a specialist ultrasound examination that assesses the risk of chromosomal abnormalities in the developing fetus by measuring a small, fluid-filled space at the back of the baby's neck — the nuchal translucency. In early pregnancy, all fetuses have some fluid in this space. The amount of fluid normally peaks between 11 and 13 weeks and then resolves. When it is elevated above the expected range for the baby's size at this gestational window, it becomes a significant marker.
The reason the scan is performed precisely between 11 and 13 weeks is not arbitrary. Before 11 weeks, the fetal structures are too small for reliable measurement. After 14 weeks, the fluid is typically absorbed by the fetal lymphatic system and the window closes — the NT is no longer measurable. This four-week window is the only time in pregnancy when this particular assessment is possible, which is why timing matters so much.
The NT scan is not just a single measurement. A well-conducted NT examination at a specialist fetal medicine clinic includes:
- Measurement of crown-rump length (CRL) to confirm gestational age and ensure the NT is being measured at the correct time
- Nuchal translucency measurement in the neutral position with specific technique criteria (FMF-accredited protocol)
- Assessment of the fetal nasal bone — present in most normal fetuses, absent in approximately 65–70% of Down syndrome cases at this gestation
- First-trimester anatomy survey — assessing the brain, abdominal wall, bladder, limbs, and umbilical cord insertion
- Uterine artery Doppler assessment for pre-eclampsia risk (performed as part of the combined first-trimester screen)
- Placental localisation and assessment of the uterine cavity
What Does the NT Scan Measure? — Nuchal Translucency + Nasal Bone Assessment
The nuchal translucency is measured as the maximum thickness of the subcutaneous translucency between the skin and the soft tissue overlying the cervical spine. The measurement is expressed in millimetres and then compared to the expected range for the baby's crown-rump length at that gestation. The result is expressed as either an absolute value (e.g., 2.1 mm) or as a multiple of the median (MoM) for the gestational age — the MoM form allows meaningful comparison across pregnancies at different gestational ages.
It is important to understand that the NT measurement is not interpreted in isolation. Its clinical significance depends entirely on the context — particularly the combined first-trimester screening result, maternal age, and the presence or absence of the fetal nasal bone. An NT of 2.8 mm carries very different implications in a 28-year-old with low-risk serum markers compared to a 42-year-old with abnormal PAPP-A levels.
The Fetal Nasal Bone — NT NB Scan
At the same 11 to 13 week appointment, the fetal nasal bone is assessed. The nasal bone appears as a bright line on ultrasound and is present in more than 99 percent of chromosomally normal fetuses at this gestation. Conversely, it is absent in approximately 65 to 70 percent of fetuses with Trisomy 21 (Down syndrome) in the first trimester — making its absence one of the most powerful single markers for chromosomal abnormality available at this stage.
The combined assessment of nuchal translucency and nasal bone status — commonly referred to as the NT/NB scan or NT NB scan — significantly improves the sensitivity of first-trimester chromosomal risk assessment compared to the NT measurement alone. When the nasal bone is absent in a fetus with an elevated NT, the combined risk calculation shifts substantially upward. When the nasal bone is clearly present in a fetus with a mildly elevated NT, this provides meaningful reassurance.
Reliable nasal bone assessment requires specialist training and specific technique — it should be performed by a clinician with FMF certification or equivalent fetal medicine subspecialty training, not at a general diagnostic centre.
Combined First-Trimester Screening — More Than Just the NT Measurement
The NT scan alone has a detection rate of approximately 64 to 70 percent for Trisomy 21 at a 5 percent false positive rate. This is useful but not optimal. When the NT measurement is combined with two maternal blood tests — Pregnancy-Associated Plasma Protein-A (PAPP-A) and free beta human chorionic gonadotrophin (free beta-hCG) — the detection rate increases to approximately 85 to 90 percent at the same 5 percent false positive rate. This combined assessment is called the Combined First-Trimester Screen, and it is the standard-of-care approach to first-trimester chromosomal risk assessment.
At the Fetal & Genetic Clinic, the NT scan is performed as part of this complete Combined First-Trimester Screen — not as an isolated measurement. The blood tests are taken and the ultrasound performed at the same visit, and a single combined risk figure is generated using validated software.
How the Combined Screen Calculates Your Risk
The combined risk calculation integrates five pieces of information into a single probability figure:
- Maternal age: Trisomy 21 risk increases with age — from approximately 1 in 1,000 at age 25, to 1 in 270 at age 35, to 1 in 85 at age 40.
- Crown-rump length and gestational age: Ensures the NT is interpreted at the correct gestational window.
- NT measurement: Expressed as a multiple of the median (MoM) — values above 2.5 MoM are generally considered elevated.
- Serum PAPP-A: Low levels are associated with increased chromosomal risk and also with placental dysfunction and pre-eclampsia.
- Serum free beta-hCG: Elevated levels are associated with Trisomy 21; reduced levels with Trisomy 18.
The output is a single risk figure expressed as a ratio — for example, 1 in 120 for Trisomy 21. Results below 1 in 1,000 are generally considered low risk; results above 1 in 100 are considered high risk and warrant further testing. Results between 1 in 100 and 1 in 1,000 are intermediate and are typically managed with NIPT.
NT Scan Normal Range — What the Measurements Mean
Many parents become anxious about their NT measurement without the context to interpret it. The most important principle is this: the NT measurement is not high or low in absolute terms — it must be assessed relative to the baby's crown-rump length at the time of the scan, and interpreted alongside the combined first-trimester screening result.
As a general guide, NT measurements below 2.5 mm at 11 to 13 weeks are reassuring in the vast majority of pregnancies. NT measurements above 3.5 mm are associated with a significantly elevated risk of chromosomal and structural abnormalities, though the majority of fetuses — particularly those with NT between 3.5 and 4.4 mm — are chromosomally normal.
The table below shows the approximate outcomes by NT measurement range, based on published fetal medicine literature:
| NT Measurement | Chromosomally Normal (%) | Down Syndrome (%) | Other Trisomy (%) | Structural Defect (%) |
|---|---|---|---|---|
| < 3.4 mm | ~97–99 | ~1 | < 1 | ~1 |
| 3.5 – 4.4 mm | ~90 | ~6 | ~2 | ~4 |
| 4.5 – 5.4 mm | ~80 | ~11 | ~3 | ~7 |
| 5.5 – 6.4 mm | ~65 | ~18 | ~5 | ~10 |
| > 6.5 mm | ~30–45 | ~20–30 | ~10 | ~15–20 |
Important note: These figures are population averages. The risk for any individual pregnancy also depends on maternal age, serum marker results, and the presence or absence of the fetal nasal bone. Do not interpret the table in isolation — discuss your specific result with Dr. Gupta.
What Happens if Your NT Scan Result Is Abnormal?
Receiving an elevated NT result — or a high-risk combined first-trimester screening result — is an understandably anxious experience for any expectant parent. The first, most important thing to understand is this: an elevated NT does not mean your baby definitely has a chromosomal or structural abnormality. It means the probability of certain conditions is elevated and that further assessment is warranted.
The appropriate next step depends on how elevated the NT is, what the combined risk figure shows, your maternal age, and whether the nasal bone was present. Dr. Gupta will discuss your specific result in its full clinical context and recommend the most appropriate pathway. The table below provides a general framework:
| Risk Level | Result Interpretation | Recommended Next Step |
|---|---|---|
| Low risk (< 1:1000) | NT within normal range, serum markers reassuring | Routine anomaly scan at 19 weeks. No further chromosomal testing needed unless requested. |
| Intermediate risk (1:100–1:1000) | NT borderline or serum markers slightly elevated | NIPT (cell-free DNA testing) recommended for refined risk assessment. |
| High risk (> 1:100) | NT significantly elevated or combined risk above threshold | CVS at 12–13 weeks OR amniocentesis at 16 weeks for definitive chromosomal diagnosis. |
| Very high NT (> 3.5 mm) | Regardless of combined risk score | Fetal echocardiography at 16 weeks (early echo) in addition to chromosomal testing. |
| NT > 6.5 mm | Major risk of chromosomal or structural abnormality | Urgent genetic counselling + invasive testing + detailed cardiac and structural assessment. |
Understanding Each Next Step
- NIPT (Non-Invasive Prenatal Testing): A highly sensitive blood test from 10 weeks onwards that analyses cell-free fetal DNA in the mother's bloodstream. It screens for Trisomy 21, 18, and 13 with detection rates above 99% for Down syndrome. It carries no risk to the fetus. However, it is a screening test — a positive NIPT result must be confirmed by CVS or amniocentesis before any irreversible decision is made.
- CVS — Chorionic Villus Sampling at 12–13 Weeks: A definitive diagnostic test performed by inserting a fine needle transabdominally under continuous ultrasound guidance to sample a small amount of placental tissue. It provides a definitive chromosomal diagnosis with results available in 1 to 2 days (FISH/QF-PCR) or 14 days (full karyotype). Procedure-related miscarriage risk approximately 1 in 300 in experienced hands. Dr. Gupta has performed this procedure hundreds of times.
- Amniocentesis at 16 Weeks: A definitive diagnostic test sampling amniotic fluid. Provides the same chromosomal diagnostic certainty as CVS. Procedure-related fetal loss rate approximately 1 in 500. The advantage over CVS is a marginally lower procedural risk; the disadvantage is the later gestational timing.
- Fetal Echocardiography: When NT exceeds 3.5 mm, the risk of structural cardiac defects increases substantially — independent of chromosomal findings. An early echocardiography assessment at 16 weeks is recommended in these cases, in addition to chromosomal testing.
It is equally important to understand what an elevated NT does not necessarily mean. A chromosomally normal fetus with an NT between 3.5 and 4.4 mm who has a normal cardiac assessment and a normal 19-week anomaly scan has a broadly favourable prognosis. The elevated NT resolves in most cases and does not, by itself, predict a poor outcome.
NT Scan vs NIPT — Which Test Should You Have?
This is one of the most common questions at first-trimester consultations, and the answer depends on what you are trying to achieve and what you would do with the result.
- NT scan (Combined First-Trimester Screen): Available from 11 weeks. Provides a risk assessment for Trisomy 21, 18, and 13 combined with assessment of the fetal anatomy, nasal bone, uterine arteries, and pre-eclampsia risk. Does not assess sex chromosome abnormalities or microdeletions. Detection rate ~85–90% for T21 at 5% false positive rate. Cost is lower than NIPT.
- NIPT (Non-Invasive Prenatal Testing): Available from 10 weeks. Blood test only — no ultrasound component. Detection rate >99% for T21 at <0.1% false positive rate. Can also screen for sex chromosome abnormalities and microdeletions (depending on the panel). Does not assess fetal anatomy, nasal bone, uterine arteries, or pre-eclampsia risk. More expensive than the combined screen.
- Both together: The optimal approach for many high-risk pregnancies combines both: the combined first-trimester screen for the full first-trimester clinical assessment, followed by NIPT if the combined risk is intermediate (1:100–1:1,000). Both together provide the highest screening accuracy and the most complete first-trimester assessment.
Dr. Gupta will advise on the most appropriate testing pathway for your specific risk profile and gestational age during your consultation.
Why Choose Dr. Ashutosh Gupta for Your NT Scan in Delhi?
The NT scan is the most technically demanding ultrasound performed in pregnancy — the measurement window is narrow (11 to 13 weeks 6 days), the technique must meet strict criteria, and the interpretation requires specialist clinical judgment to contextualise the finding accurately. Here is why a specialist fetal medicine clinic makes a measurable difference:
- Performed by a DM-qualified fetal medicine specialist: Every NT scan at the Fetal & Genetic Clinic is performed personally by Dr. Ashutosh Gupta — not a sonographer, not a radiologist. Dr. Gupta's DM in Medical Genetics from SGPGIMS means he can interpret not just the measurement but its full chromosomal and genetic implications, and advise on the appropriate next step in the same appointment.
- FMF-protocol compliant technique: The NT measurement is performed to the exact criteria established by the Fetal Medicine Foundation (FMF) — the international standard. This means the measurement is reliable, reproducible, and directly comparable to the published outcome data on which clinical decisions are based.
- Nasal bone assessment included: The nasal bone assessment (NT NB scan) is included as standard — providing the combined NT + NB risk calculation that significantly improves detection accuracy. This is not offered as standard at many diagnostic centres.
- Integrated genetic counselling if needed: If your result is elevated, Dr. Gupta provides genetic counselling in the same consultation — explaining the result clearly, walking through all testing options with their implications, and giving you the time to ask questions without pressure.
- On-site invasive procedures if required: If your result warrants CVS or amniocentesis, Dr. Gupta performs both procedures himself at the same clinic — with a procedural experience of over 3,000 invasive fetal cases. There is no referral, no waiting list, no handover to an unfamiliar clinician.
- South Delhi location — easy access: E-874, Basement, Chittaranjan Park — accessible from Greater Kailash, Kalkaji, Saket, Lajpat Nagar, and Nehru Place. Patients also come from Noida and Gurugram.
How to Prepare for Your NT Scan
The NT scan requires minimal preparation, but following these guidelines ensures the best possible image quality and the most efficient appointment:
- Bladder preparation: For most patients at 11 to 13 weeks, the uterus is large enough to be easily seen transabdominally without a full bladder. However, arriving with a comfortably full bladder (not overfull) is recommended as it can improve the ultrasound window in some cases.
- What to bring: All previous pregnancy notes and scan reports, your blood test results if serum screening has already been done, a list of any medications you are taking, and any family history information relevant to chromosomal or genetic conditions.
- Timing: Arrive five minutes early to complete any paperwork. The scan itself takes approximately 30 to 45 minutes when performed as part of the full combined first-trimester assessment. Allow additional time if genetic counselling is required following the result.
- Who to bring: You are welcome to bring your partner or a support person. There is no restriction on this.
- Blood tests: If you have not already had your PAPP-A and free beta-hCG blood tests taken, these can be arranged. Ideally these are taken a few days before the scan so results are available on the day — but same-day or post-scan blood testing is also manageable.
Frequently Asked Questions — NT Scan in Delhi
Book Your NT Scan in Delhi
The first trimester is the most time-sensitive window in pregnancy for chromosomal screening — and the NT scan must be booked between 11 and 13 weeks 6 days to be valid. If you are approaching this window, do not delay.